Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials-Reference-Cited by-同舟云学术

Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials

Published:1997-06 Issue:3 Volume:11 Page:473-482
ISSN:0269-2813
Container-title:Alimentary Pharmacology and Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Carlsson R.,Galmiche J.-P.,Dent J.,Lundell L.,Frison L.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.1997.00167.x/fullpdf

Reference45 articles.

1. 1JE Richter Dyspepsia: Organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol 1991, 11 (Suppl. 182): 11 -6 .

2. 2PL Brunnen, AM Karmody, and CD Needham Severe peptic oesophagitis. Gut 1969, 11 : 831 -7 .

3. 3L Loof, P Gotell, and B Elfberg The incidence of reflux esophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol 1993, 11 : 113 -8 .

4. 4A Sonnenberg Epidemiologie und Spontanverlauf der Reluxkrankheit. In: Blum AL, Siewert JR, eds. Refluxtherapie. Berlin: Springer Verlag, 1981 : 85-106.

5. 5 M Wienbeck, and J Barnert Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989, 11 (Suppl. 156): 7 -13 .

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Liujunzi Decoction on Gastroesophageal Reflux Disease: A Systematic Review and Meta Analysis;Journal of Herbal Medicine;2024-09

2. Potassium-competitive acid blockers: rethinking acid suppression for gastroesophageal reflux disease and Helicobacter pylori;Postgraduate Medicine;2024-02-17

3. Frontiers in Endoscopic Treatment for Gastroesophageal Reflux Disease;Digestion;2023-08-17

4. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review;Gastroenterology;2022-04

5. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021;Journal of Gastroenterology;2022-02-28